Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. (Q31160841)

29 June 2017

Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. (English)

1 reference

29 June 2017

0 references

0 references

4

Ingrid Arijs

0 references

Vicky De Preter

1

Vicky De Preter

0 references

Paul Rutgeerts

7

Paul Rutgeerts

0 references

Marie Joossens

Marie Joossens

3

0 references

Christophe Matthys

Christophe Matthys

5

0 references

Séverine Vermeire

6

Severine Vermeire

1 reference

29 June 2017

2

Kathleen Machiels

1 reference

29 June 2017

8

Kristin Verbeke

1 reference

PubMed ID

24811995

29 June 2017

language of work or name

English

0 references

publication date

8 May 2014

1 reference

29 June 2017

1 reference

29 June 2017

64

1 reference

29 June 2017

3

1 reference

29 June 2017

447-458

1 reference

Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases

29 June 2017

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Short chain fatty acids in the human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

A simple index of Crohn's-disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Validity and reproducibility of an adolescent web-based food frequency questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

The relationship between diet and subclinical atherosclerosis: results from the Asklepios Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Development, validation and utilisation of food-frequency questionnaires - a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Characterization of inflammatory bowel disease with urinary metabolic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Functional analysis of colonic bacterial metabolism: relevant to health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Microbial influences in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway*

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Oxidation of short and medium chain C2-C8 fatty acids in Sprague-Dawley rat colonocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Modeling the inhibitory effects of organic acids on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Intestinal concentrations of free and encapsulated dietary medium-chain fatty acids and effects on gastric microbial ecology and bacterial metabolic products in the digestive tract of piglets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Impact of intestinal microbiota on intestinal luminal metabolome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Analysis of bacterial bowel communities of IBD patients: what has it revealed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Luminal sulfide and large intestine mucosa: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Generation of gaseous sulfur-containing compounds in tumour tissue and suppression of gas diffusion as an antitumour treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Influence of dietary protein supplements on the formation of bacterial metabolites in the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Postoperative and long-term results of ileal pouch-anal anastomosis for ulcerative colitis and familial polyposis coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Potential applications of breath isoprene as a biomarker in modern medicine: a concise overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

An investigation of fecal volatile organic metabolites in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

Metabolomics of Fecal Extracts Detects Altered Metabolic Activity of Gut Microbiota in Ulcerative Colitis and Irritable Bowel Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-306423

10.1136/GUTJNL-2013-306423

21 January 2018

Identifiers

DOI

1 reference

29 June 2017

1 reference

PubMed ID

24811995